Pembrolizumab

产品编号 HY-19215
产品分类 抑制剂
CAS号 1374853-91-4
分子式 N/A
分子量 146266.20
品牌 华韵生物
规格 1mg 5mg 10mg
应用 Pembrolizumab is a potent, highly selective, fully humanized immunoglobulin (Ig) G4-kappa monoclonal antibody against PD-1 with potential immune checkpoint inhibitory and antineoplastic activities. MW : 146.286 KD. In addition to Melanoma and Lung carcinoma, pembrolizumab has also demonstrated efficacy in other advanced solid tumors and hematologic malignancies. Pembrolizumab had an acceptable side-effect profile and showed antitumor activity in patients with advanced non-small-cell lung cancer.
品牌 货号 纯度 规格 目录价(CNY) 会员价(CNY) 数量 购物车
华韵生物 HY-19215-1mg 1mg ¥3860.00
华韵生物 HY-19215-5mg 5mg ¥11577.00
华韵生物 HY-19215-10mg 10mg ¥19305.00
COA查询 查询MSDS 大包装询盘
CAS号 1374853-91-4
分子式 N/A
分子量 146266.20
状态 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。
储备液的保存方式和期限：-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。
为了提高溶解度，请将管子加热至37℃，然后在超声波浴中震荡一段时间。
存储 Pure form：
-20°C，3 years / 4°C，2 years ;
In solvent：
-80°C，6 months / -20°C，1 month ;
背景介绍 Pembrolizumab is a potent, highly selective, fully humanized immunoglobulin (Ig) G4-kappa monoclonal antibody against PD-1 with potential immune checkpoint inhibitory and antineoplastic activities. MW : 146.286 KD. In addition to Melanoma and Lung carcinoma, pembrolizumab has also demonstrated efficacy in other advanced solid tumors and hematologic malignancies. Pembrolizumab had an acceptable side-effect profile and showed antitumor activity in patients with advanced non-small-cell lung cancer.
暂无相关论文！
说明书更新中，请联系业务员索取！
暂无技术文章！
象形图
警示语
Class
警告声明
UNub
危险声明
Packing Group
搜索质检报告(COA)
相关产品
Cyclo(-D-Leu-D-Pro)
274680-11-4
Polyinosinic acid
30918-54-8
DSPE-PEG-CRGD
PEG6000
25322-68-3
PEG4000
25322-68-3
PEG500
25322-68-3
PEG200
25322-68-3
PEG1500
25322-68-3